TP53 and cancer: On the other hand, most cancers cannot thrive without fighting telomere attrition by the overexpression of telomerase (Blasco, 2005), and loss‐of‐function mutations in the genes p53, p16, and pRb desensitize cancer cells to apoptosis and senescence (Sherr & McCormick, 2002).